Relmada Therapeutics (RLMD)
Develops NDV-01 for NMIBC and sepranolone for Prader-Willi syndrome.
$3.91
vs last close−0.33 (−7.78%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.14
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.62−$0.58−$0.30−$0.30−$0.27−$0.22−$0.11Pending
Estimate−$0.70−$0.31−$0.25−$0.04−$0.14−$0.18−$0.20−$0.14
Surprise+11.4%−87.1%−20.0%−650.0%−92.9%−22.2%+44.9%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.23 | — | — |
| Sep 2027 | −$0.21 | — | — |
| Jun 2027 | −$0.19 | — | — |
| Mar 2027 | −$0.17 | — | — |
| Dec 2026 | −$0.16 | — | — |
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.20 | −$0.11 | +44.9% |
| May 2026 | −$0.18 | −$0.22 | −22.2% |
| Mar 2026 | −$0.14 | −$0.27 | −92.9% |
| Nov 2025 | −$0.04 | −$0.30 | −650.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.23 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.21 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.19 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.17 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.16 | — | — | $0 | — | — | — |
| Nov 12, 2026 | −$0.14 | — | — | $0 | — | — | — |
| Aug 6, 2026 | −$0.20 | −$0.11 | +44.9% | — | — | — | −8.0% |
| May 12, 2026 | −$0.18 | −$0.22 | −22.2% | — | — | — | +0.5% |
| Mar 19, 2026 | −$0.14 | −$0.27 | −92.9% | — | — | — | −2.9% |
| Nov 13, 2025 | −$0.04 | −$0.30 | −650.0% | — | — | — | +1.8% |
| Aug 7, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Mar 19, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 5, 2022 | |||||||
| Mar 23, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 10, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 23, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 15, 2020 | |||||||
| Mar 26, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Sep 24, 2019 | |||||||
| May 14, 2019 | |||||||
| Feb 13, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Sep 28, 2018 | |||||||
| May 14, 2018 | |||||||
| Feb 12, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Sep 28, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 10, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Sep 12, 2016 | |||||||
| May 9, 2016 | |||||||
| Feb 5, 2016 | |||||||
| Nov 6, 2015 | |||||||
| Sep 11, 2015 |